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Do caveolae regulate signaling 
pathways? The broad spectrum 
of signaling pathways sensitive to 
caveolae or caveolins is remarkable, 
with impacts on gene expression, cell 
proliferation, anchorage dependence of 
cell growth, directional cell migration, 
extracellular matrix remodeling, and 
so on. Since caveolins are also found 
outside of caveolae, some of the 
functions assigned to caveolin may 
not be related to caveolae, but it is 
clear that caveolae directly regulate 
numerous signaling pathways. Two 
types of mechanism have been 
described by which caveolae fine-
tune or activate/deactivate signaling 
cascades. One is the differential 
lateral plasma membrane distribution 
of signaling molecules within or 
outside of caveolae. The second is 
the movement of caveolae residents 
between the cell surface and interior 
due to the translocation of caveolae 
between the plasma membrane and 
the endomembrane system, where   
caveolae presumably lose their 
characteristic shape. In both cases, the 
change in localization results in different 
signaling outputs. Signaling molecules 
(membrane receptors, non-receptor 
kinases and adaptors) can be recruited 
to caveolae through direct binding to 
caveolins or by caveolin-independent 
mechanisms. 
Is the lack of caveolae associated with 
human disease? Many oncogenes 
induce a marked reduction in caveolin-1 
expression, resulting in loss of caveolae 
from transformed cells. This correlates 
with increased proliferation and 
anchorage-independent cell growth, 
but in certain cancers caveolin-1 
expression is advantageous for cancer 
progression and promotes metastasis. 
Understanding the role of caveolae 
in cancer progression will require 
comprehensive knowledge about the 
role of caveolae and/or caveolin in 
regulating pathways essential for cell 
adhesion, proliferation and migration. 
Mutations in caveolin-1 and cavin-1 
have been linked to lipodystrophy 
in humans, suggesting that the 
proposed function of caveolae in lipid 
homeostasis is altered in affected 
individuals. Similarly, mutations in 
caveolin-3 have been linked to various 
muscular disorders, including limb 
girdle muscular dystrophy and rippling 
muscle disease. The predominantly 
cardiovascular phenotypes of caveolin-
deficient mice also suggest a potential 
role in human cardiovascular disorders. 
Clearly, caveolae are needed for a 
healthy organism.
What remains to be explored? 
The central question we cannot yet 
answer is why it is advantageous 
for certain cells to contain 
caveolae. In other words, what is 
the physiological function of this 
unique plasma membrane domain? 
Although caveolae are implicated 
in many signaling cascades and 
cellular processes, the reason for the 
shape of this membrane domain is 
unclear. The mechanosensory and 
mechanotransduction capability of 
caveolae may be an important specific 
function that differentiates caveolae 
from other membrane domains. A 
clearer understanding of how caveolae 
sense and transmit physical forces 
will undoubtedly shed light on their 
physiological role. It is currently unclear    
whether other functions of caveolae, 
such as their role in cholesterol 
homeostasis or specific roles in a given 
signaling pathway, are related to their 
role in mechanosensing. Experimental 
models for exploring the connections 
between apparently unrelated and 
diverse caveolae functions will help 
us to draw a clear picture of the true 
function of caveolae.
Where can I find out more?
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The endosomal sorting complexes 
required for transport (ESCRT) 
assemble into a multisubunit machinery 
that performs a topologically unique 
membrane bending and scission 
reaction away from the cytoplasm. This 
evolutionarily highly conserved process 
is required for the multivesicular body 
(MVB) pathway, cytokinesis and HIV 
budding. The modular setup of the 
machinery with five distinct ESCRT 
complexes (ESCRT-0, -I, -II, -III and 
the Vps4 complex) that have a clear 
division of tasks — from interaction 
with ubiquitinated membrane 
proteins to membrane deformation 
and abscission — allows them to be 
flexibly integrated into these three very 
different biological processes (Figure 1). 
In the first of these processes, the 
MVB pathway delivers ubiquitinated 
membrane proteins and lipids into 
lysosomes for degradation. During 
MVB sorting the entire ESCRT 
machinery sequentially assembles 
on endosomes, where it generates 
MVB vesicles by budding the limiting 
endosomal membrane away from 
the cytoplasm. An ESCRT-mediated 
membrane scission step finally releases 
the mature MVB vesicle into the lumen 
of the organelle. Since this process is 
required for membrane protein turnover, 
it is critical for the regulation of cell 
surface receptor signaling in cells and 
during development.
In the second process, at the end 
of cytokinesis, ESCRT complexes 
coordinate membrane abscission 
with microtubule disassembly at the 
midbody to physically separate the two 
daughter cells. 
Finally, in the third process ESCRT 
complexes are hijacked during HIV 
budding at the surface of infected host 
cells where they catalyze the scission 
of the membrane stalk that connects 
the budding virus with the host cell. 
Despite fundamental differences, all 
three processes require a topologically 
equivalent membrane budding and 
scission reaction — away from the 
cytoplasm — which is catalyzed by 
the coordinated action of the ESCRT 
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Figure 1. ESCRT-dependent processes.
ESCRT complexes catalyze a topologically distinct membrane-remodelling event: budding 
and scission of membranes away from the cytosol. During multivesicular body (MVB) sorting 
the ESCRT machinery generates intraluminal vesicles (diameter of ~25 nmeast and ~50 nm in 
human cells) of MVBs to deliver ubiquitinated membrane proteins into lysosomes for degra-
dation. During cytokinesis ESCRT complexes catalyze the final membrane abscission at the 
midbody. Additionally, the ESCRT machinery is required for the release of certain enveloped 
viruses (i.e. human immunodeficiency virus, HIV) from the surface of infected cells.complexes (Figure 1). While the MVB 
pathway requires all five ESCRT 
complexes, cytokinesis and HIV 
budding employ only three ESCRT 
complexes. 
The components of the ESCRT 
machinery were first characterized in 
yeast as part of the so-called vacuolar 
protein sorting (vps) mutants, which 
could no longer transport proteins 
into the vacuole (the yeast equivalent 
of the lysosome). Out of these 46 
vps mutants, 13 mutants displayed a 
similar phenotype, characterized by 
an exaggerated prevacuolar organelle 
(aberrant endosomes) called the 
‘class E compartment’. All 13 ‘class 
E’ mutants were deficient in MVB 
biogenesis and blocked the delivery of 
membrane proteins into the vacuole. 
Biochemical characterization of these 
yeast mutants first resulted in the 
identification of the ESCRT-I complex 
and subsequently defined the ESCRT-II 
and ESCRT-III complexes. Earlier the 
AAA-ATPase Vps4 had been found to 
be required for pre-vacuolar transport. 
Now it became clear that Vps4 
disassembles the ESCRT complexes 
from endosomes and recycles them 
back to the cytoplasm to maintain the 
function of the MVB pathway. All 13 
vps ‘class E’ genes are evolutionarily 
highly conserved and multiple isoforms 
exist for many of the ESCRT subunits 
in many higher organisms. However, 
individual roles of the respective 
isoforms are poorly established. 
Because the function of the ESCRT 
machinery is best understood in 
the MVB pathway in yeast, we will 
predominantly focus on this process 
and thus apply yeast nomenclature in 
the figures. In the text, we will refer first 
to the yeast nomenclature and then 
additionally to the names and mutant 
phenotypes of ESCRT genes in higher 
organisms. 
ESCRT-0
The ESCRT-0 complex initiates the 
MVB pathway. It is the first complex 
of the ESCRT machinery that localizes 
to endosomes and does so via an 
interaction with an endosome-enriched 
phospholipid, phosphatidylinositol-
3-phosphate (PI3P) (Figure 2). On 
endosomes, ESCRT-0 binds to 
ubiquitin moieties that are attached 
to membrane proteins destined for 
degradation, and thus executes the 
first sorting step in the MVB pathway. 
ESCRT-0 is a 1:1 heterodimer of 
Vps27/HRS (HGF-regulated tyrosine kinase substrate) and Hse1/STAM 
(signal transducing adaptor molecule). 
Vps27/HRS and Hse1/STAM interact 
via long coiled-coil GAT domains. The 
FYVE zinc finger domain of Vps27/HRS 
binds PI3P, which directs the entire 
ESCRT-0 complex to endosomes. The 
ESCRT-0 complex contains multiple 
ubiquitin-binding domains: Hse1/
STAM contains one VHS domain and 
one ubiquitin interaction motif (UIM). 
Vps27/HRS contains a VHS domain 
plus one double-sided UIM (HRS) or 
two separated UIMs (Vps27). Hence, a 
single ESCRT-0 complex can bind up to 
five different ubiquitinated membrane 
proteins or multiple ubiquitin moieties 
of poly-ubiquitinated cargo. Both 
possibilities are not mutually exclusive 
and such multivalent binding may help 
to concentrate ubiquitinated membrane 
proteins at the initial step of the MVB 
pathway. Cargo concentration on early endosomes might additionally 
be supported by the formation of 
flat clathrin lattices that co-localize 
with HRS and may be recruited by its 
carboxy-terminal clathrin box. 
It seems that Vps27/HRS is key 
to the initiation of the MVB pathway, 
not only by binding to ubiquitinated 
cargo and PI3P, but also because 
it recruits the ESCRT-I complex. 
Vps27/HRS binds directly to the 
amino terminus of the Vps23/TSG101 
subunit of ESCRT-I via its carboxy-
terminal P(T/S)AP motif (Figure 2). 
Interestingly ESCRT-0 is only found in 
fungi and animals. Protists and plants 
lack ESCRT-0 and yet still employ 
the ESCRT-dependent MVB pathway 
for membrane protein degradation. 
Probably a different, as yet unknown 
adaptor complex is used to recruit 
ESCRT-I to endosomes in these 
organisms.
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Figure 2. Model for cargo clustering and sequential assembly of the ESCRT complexes.
ESCRT-0 (brown) initiates the MVB pathway. ESCRT-0 binds to PI3P and clusters ubiquitinated membrane proteins via multiple ubiquitin-binding 
domains. ESCRT-I (green) is recruited by ESCRT-0 (Vps27) and also binds to ubiquitinated cargo. ESCRT-II (blue) interacts via the Glue domain 
of Vps36 with ESCRT-I, PI3P and cargo. The ESCRT-II subunit Vps25 serves as a nucleation point for stepwise assembly of the filamentous 
ESCRT-III complex (yellow–orange), which sequesters cargo and drives inward budding of the vesicle.ESCRT-I 
ESCRT-I is a soluble hetero-tetramer 
consisting of Vps23/TSG101, Vps28, 
Vps37(A–D) and Mvb12(A,B) or 
ubiquitin-associated protein 1 (UBAP1) 
(Figure 2). Its efficient recruitment from 
the cytoplasm to endosomes requires 
protein–protein interactions with the 
ESCRT-0 complex. UBAP1-containing 
ESCRT-I appears to be more specific 
for MVB sorting, whereas Mvb12A/B-
containing ESCRT-I also functions 
during HIV budding. 
ESCRT-I forms a rigid 25 nm long 
rod-shaped complex. On one end, the 
UEV domain of Vps23/TSG101 interacts 
with ESCRT-0 and ubiquitinated 
membrane proteins. Since UBAP1 and 
yeast Mvb12 bind ubiquitin, ESCRT-I 
could bind two ubiquitin moieties on 
endosomes. At the opposite end of the 
ESCRT-I rod, Vps28 binds to the GLUE 
domain of the ESCRT-II protein Vps36/
Eap45 and thereby interacts with the 
ESCRT-II complex. In addition to cargo 
sorting, ESCRT-I together with ESCRT-II 
is capable of budding membranes 
into the lumen of giant unilamellar 
vesicles. The rigid architecture and size 
of ESCRT-I and ESCRT-II (see below) may help to stabilize the bud neck of a 
growing vesicle. 
ESCRT-II
ESCRT-II is a hetero-tetrameric protein 
complex. It consists of Vps36/Eap45 
and Vps22/Eap22 and two Vps25/
Eap20 molecules. While Vps36/Eap45 
and Vps22/Eap22 tightly interact with 
each other, one Vps25/Eap20 molecule 
binds to Vps36/Eap45 and the other 
one to Vps22/Eap22, thus generating 
the two arms of the characteristic 
Y-shaped structure of the ESCRT-II 
complex (Figure 2). The GLUE domain 
of Vps36/Eap45  is attached to the 
base of the Y and functions as a hub 
that connects to Vps28 of ESCRT-I and 
can bind simultaneously to PI3P and 
ubiquitin. 
Thus, each of the three early ESCRT 
complexes (ESCRT-0, -I, and -II) can 
interact with ubiquitinated cargo, and 
it seems likely that they cooperate 
in some way to sort ubiquitinated 
membrane proteins into the MVB 
pathway. Cargo molecules might be 
transferred from one ESCRT complex 
to another, like on a conveyor belt. 
Alternatively ESCRT-0, -I and -II could interact simultaneously with different 
membrane proteins and thereby 
generate a sorting domain on the 
surface of endosomes that matures into 
a site of MVB formation (Figures 2 and 
3). While cargo is collected, ESCRT-I 
together with ESCRT-II could initiate 
the budding process of the endosomal 
membrane. At the same time, both 
arms of ESCRT-II (Vps25/Eap20) could 
already interact with one copy of the 
first ESCRT-III subunit, Vps20/CHMP6 
(charged multi-vesicular body protein 6), 
and convert it into an active nucleator 
for ESCRT-III assembly on endosomes. 
ESCRT-III
In contrast to the early ESCRT 
complexes (ESCRT-0, -I and -II), which 
form stable protein complexes in the 
cytoplasm, the ESCRT-III complex only 
transiently assembles on endosomes. 
The ESCRT-III complex consists of 
four core subunits, Vps20/CHMP6, 
Snf7/CHMP4(A–C), Vps24/CHMP3 
and Vps2/CHMP2(A,B) (Figures 2 and 
3), and three accessory components, 
Did2/CHMP1(A,B), Vps60/CHMP5 and 
Ist1 (Figure 3). The core subunits are 
relatively small, 221–241 amino-acid 
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Figure 3. Membrane scission and ESCRT-III disassembly by Vps4.
The ESCRT-III subunits Vps24 and Vps2 terminate assembly of the ESCRT-III filament (orange) 
on the endosome surface. Vps2 together with Did2, Ist1 and Vps60 build a recruitment complex 
for the AAA-ATPase Vps4 and its cofactor Vta1. Once assembled, the Vps4 complex (pink) cat-
alyzes disassembly of the ESCRT-III filament in an ATP-driven reaction. ESCRT-III disassembly 
terminates each round of the MVB pathway, which results in the generation of a cargo-laden 
25 nm MVB vesicle (50 nm in human cells). 
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 proteins with similar biochemical 
properties and probably adopt a 
common molecular architecture. Their 
amino-terminal region consists of two 
helices (a1, a2) that form a 7 nm hairpin
structure important for membrane 
binding and homo- or hetero-
dimerization. In the cytoplasm, the 
negatively charged carboxy-terminal 
region (a5 and a6) folds back on the 
positively charged amino-terminal 
hairpin, which confers an autoinhibitory
mechanism that stabilizes the inactive 
monomers. The carboxyl terminus also 
harbors the so-called MIT (microtubule-
interacting and transport)-interacting 
motifs (MIMs) for interaction with the 
AAA-ATPase Vps4. 
Despite their structural similarity, 
each ESCRT-III subunit has a specific 
function. The ordered assembly into the
active filament begins when ESCRT-II 
converts Vps20 into an active nucleator,
which triggers the stepwise homo-
oligomerization of Snf7 (Figure 2). This 
oligomerization is capped by binding 
of Vps24 to the last Snf7 protomer. 
In turn, Vps24 recruits Vps2, which 
completes the assembly of the ESCRT-
III filament (Figure 3). While the precise 
stoichiometry of ESCRT-III has not been
determined, the Snf7 homo-oligomer 
appears to be its major component. 
The activation of ESCRT-III molecules 
requires a series of conformational 
changes that relieve autoinhibition, 
stabilize membrane binding, enable 
interaction with other ESCRT-III 
molecules and expose the MIM domain
The growing ESCRT-III complex recruits
deubiquitinases, which mediate cargo 
deubiquitination and thus ubiquitin 
recycling prior to vesicle formation. 
These include AMSH (associated 
molecule with the SH3 domain of 
STAM), USP8/UBPY (ubiquitin-specific 
protease 8) and in yeast Doa4 (which 
binds via Bro1 to Snf7). It is possible 
that at this stage of the MVB pathway 
the cargo proteins have been encircled 
by a ring-shaped ESCRT-III filament that
can be observed upon overexpression 
of CHMP4 in vivo and in vitro. Now 
deubiquitination can safely take place 
without the risk of cargo evading 
lysosomal degradation. Although it 
has not been demonstrated, cargo 
deubiquitination may help to release 
the early, ubiquitin-binding ESCRT 
complexes into the cytoplasm. 
In vivo and in vitro data suggest a 
key role for the ESCRT-III complex 
in all ESCRT-mediated membrane 
remodeling (budding and scission)  
reactions, although the mechanism 
is not understood. Hence, ESCRT-III 
filaments may have a dual role during 
MVB sorting: cargo sequestration 
within the site of MVB vesicle formation 
and membrane budding/scission.
Vps4 complex
ESCRT-III and the Vps4 complex are 
the most conserved building blocks 
of the ESCRT machinery. Homologues 
of Vps4 and ESCRT-III subunits are 
found in all eukaryotic species and 
in certain prokaryotic organisms: 
Crenarcheota of the genus Sulfolobus. 
The Vps4 complex consists of the type 
I AAA-ATPase Vps4 and its co-factor 
Vta1. In the cytoplasm, Vps4 is an inactive protomer (monomer or dimer). 
A recruitment complex regulates the 
assembly of Vps4 onto ESCRT-III 
(Figure 3). Its central component is the 
ESCRT-III subunit Vps2/CHMP2, which 
functions together with Did2/CHMP1, 
Ist1 and Vps60/CHMP5. Since Vps2 
also completes ESCRT-III assembly, it 
provides an intrinsic timer for ESCRT-III 
disassembly. Vps4 contains an amino-
terminal MIT domain that probably 
binds first to the carboxy-terminal MIM 
domain of Vps2. Once recruited to the 
ESCRT-III complex, Vps4 assembles 
into a dodecamer, consisting of two 
stacked hexameric rings with a central 
pore. The binding of Vta1 results 
in an active Vps4–Vta1 complex 
Current Biology Vol 22 No 4
R120with enhanced ATPase activity. 
Like other AAA-ATPases, Vps4 is a 
mechanoenzyme. It invests the energy 
from ATP hydrolysis into mechanical 
power to disassemble the membrane-
bound ESCRT-III filament and thereby 
recycles its individual subunits back 
to the cytoplasm. After completion 
of ESCRT-III disassembly, the Vps4 
complex also dissociates into its 
inactive protomers. As such, the Vps4 
complex terminates each round of MVB 
cargo sorting and vesicle formation.
ESCRT mutant phenotypes associated 
with defects in the MVB pathway
Several mutations of ESCRT 
components exist in higher 
eukaryotes, including humans, 
mouse, Drosophila melanogaster 
and Caenorhabditis elegans. The 
predominant phenotype of yeast 
ESCRT mutants — a defect in the MVB 
pathway with an aberrant endosomal 
compartment — is phenocopied in 
the mutant cells of these organisms. 
As a consequence, ESCRT mutant 
cells fail to downregulate and degrade 
cell-surface signaling receptors 
(Notch, EGFR and many others), which 
frequently results in sustained receptor 
signaling and hyperproliferation in 
tissues. Yet, hyperproliferation may 
be counterbalanced by increased 
apoptosis and cell-cycle defects 
displayed by certain ESCRT mutants. 
Additionally, adverse effects may 
contribute to the complexity of 
ESCRT mutant phenotypes observed 
during the development of higher 
eukaryotes. For example, Wingless/
Wnt signaling appears to require a 
functional MVB pathway. Moreover, 
a wide range of ESCRT mutants 
in human, fly and worm cells are 
defective in autophagosome fusion 
with lysosomes, although the role of 
ESCRTs in this process is elusive. Also, 
autophagy defects in ESCRT mutants 
have been associated with reduced 
clearance of protein aggregates typical 
for neurodegenerative diseases, and 
mutations in Vps2/CHMP2B were 
described in patients with hereditary 
forms of amyotropic lateral sclerosis 
and fronto-temporal dementia.
The complexity of ESCRT mutant 
phenotypes during tissue development 
is maybe best demonstrated in 
Drosophila epithelia, where most 
ESCRT mutant cells lose cell polarity, 
which causes neoplastic transformation 
and non-cell-autonomous 
hyperproliferation of the neighboring wild-type cells. The ESCRT mutant cells 
themselves could only hyperproliferate 
once cell death was blocked. 
Mice deficient in HRS, CHMP5 
or STAM1/2 die during embryonic 
development at day 11 (E11), with 
severe morphogenesis defects. 
CHMP4B/mSnf7-2 and TSG101 
knockout mice die at days E8 and E6, 
respectively. Thus, a prominent and 
complex role for the ESCRT machinery 
during development, cancer and 
neurodegeneration is emerging.
The ESCRT machinery during 
cytokinesis
In higher eukaryotes and certain 
archaea, but not in budding yeast, the 
ESCRT machinery also executes cell 
abscission, the final membrane scission 
step that terminates cytokinesis 
(Figure 1). ESCRT-0 and ESCRT-II 
are not required for this process. The 
centrosomal protein CEP55 recruits 
TSG101 and the Bro-domain-containing 
protein Alix into two cortical rings at 
the midbody. Alix binds to and may 
activate Snf7/CHMP4. Somehow, 
ESCRT-I and Alix trigger ESCRT-III 
assembly into long helical filaments that 
extend from the midbody to the site of 
abscission. Interestingly, the ESCRT-
III subunit Did2/CHMP1B recruits the 
AAA-ATPase spastin, which severs 
the thick microtubule bundles at the 
midbody prior to membrane abscission. 
Thus, during cytokinesis ESCRT-
III filaments coordinate membrane 
scission with spastin-mediated 
microtubule disintegration. Importantly, 
Crenarchaeota, which lack other 
protofilaments such as FtsZ/tubulin 
or MreB/actin for cell division, use the 
ESCRT-III–Vps4 system instead. 
Loss or reduction of ESCRT function 
in human cells, Arabidopsis thaliana 
and Sulfolobus acidocaldarius 
frequently results in multinucleated 
cells, caused by a failure of cytokinetic 
abscission and probably subsequent 
cleavage furrow regression upon 
prolonged cytokinesis arrest. 
The ESCRT machinery during HIV 
budding
HIV and other retroviruses, such as 
Ebola and human T-lymphotropic 
virus, exploit certain components of 
the ESCRT machinery to bud out of 
infected host cells (Figure 1). ESCRT-0 
and ESCRT-II are dispensable for HIV 
budding, whereas Alix is required. Of 
the ESCRT-III subunits only CHMP4 and 
CHMP2 appear to be essential. The HIV Gag protein hijacks ESCRT-I at the 
plasma membrane. PTAP motifs in the 
Gag protein mimic the P(T/S)AP motif of 
HRS and thus recruit TSG101 to the cell 
surface. The successive recruitment of 
Alix, ESCRT-III and Vps4 is then required 
to sever the neck of the maturing virus. 
Loss of ESCRT function inhibits viral 
release with arrested buds accumulating 
on the surface of infected cells.
Outlook
While it is now clear that ESCRTs 
function as a protein sorting and 
membrane sculpting/scission 
machinery, there are still major open 
questions. Among the most pressing 
questions are the molecular mechanism 
underlying ESCRT-mediated 
membrane deformation and scission, 
and its different kinetics and energy 
requirements in the MVB pathway, 
cytokinesis and HIV budding. More 
work must be invested before we truly 
understand these processes.
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